An open labeled clinical trial to evaluate the efficacy and safety of â??Hypercumâ?? for the treatment of hypertension and associated complications

MS Natural Solutions0 个研究点目标入组 16 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Males and females of age group 18-60 years
•Subjects who are willing to give written informed consent
•Patient running with Anti Hypertensive drugs or patient having known to be a Hypertensive patient but not yet approached any system of medication.
•Diabetic Patient or Patient running with Renal Failure or Patient having Metabolic Syndrome
•Female subjects who are confirmed as non-pregnant status and agree to comply with proper contraception throughout the study duration
•Patient is willing and able to comply with all trial requirements

•Severe essential hypertension
•Significant renal insufficiency [Serum Creatinine > 159 Âµmol/L ( > 1.8 mg/dl)]
•History of cerebro-vascular disease
•Patients with a history of HIV infection, AIDS, hepatitis B or C, or other immunosuppressive disorders
•Current diagnosis or a history of malignancy
•Drug of abuse within the past 2 years
•Pregnancy or breastfeeding
•Present history of mental diseases
•Previous participation in a clinical trial within 6 months

发起方

MS Natural Solutions